Sugar-sweetened beverages and cardiovascular disease risk: an RCT

含糖饮料和心血管疾病风险:随机对照试验

基本信息

  • 批准号:
    8128446
  • 负责人:
  • 金额:
    $ 77.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-14 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Consumption of sugar sweetened beverages (SSB) has been linked to obesity and, independent of body weight, risk for diabetes and cardiovascular disease. With rising public health awareness of these potential adverse effects, consumption of artificially sweetened beverages (ASB) has increased dramatically. These low-calorie products are marketed as "diet," with the implication that they promote weight loss and improved health. However, there are no long term experimental studies of ASB and body weight or any other health outcome. Several recent prospective observational studies have linked intake of ASB to increased risk of the metabolic syndrome, type 2 diabetes, and obesity. In the proposed clinical trial, 270 young adults who habitually consume SSB will be randomly assigned to one of three groups: 1) to continue consuming habitual levels of SSB; 2) to substitute ASB for SSB; or 3) to substitute unsweetened beverages for SSB. Each group will receive home delivery of the targeted beverage for 1 year, using methods that build upon previous successful work. Careful attention will be given to assuring treatment fidelity, equivalence of treatment intensity, and avoidance of experimental confounders. The primary study endpoint will be the ratio of serum triglyceride to HDL-cholesterol concentrations. Secondary endpoints will include changes in other cardiovascular disease risk factors, body weight, dietary quality, and taste preferences. PUBLIC HEALTH RELEVANCE: Artificially sweetened beverages (ASB) raise unique and important public health questions for three reasons: 1) their consumption has increased exponentially in the US in the last 2 decades; 2) habitual drinkers of these products typically consume much more artificial sweetener than those who limit artificial sweetener intake to solid foods; and 3) ASB may have unique biological and behavioral effects, by virtue of their liquid form. However, there are no long-term controlled trials of ASB and any health outcome, leaving critically important public health questions unanswered. The present study aims to fill this critical knowledge gap, by comparing the effects of ASB, not just to sugar-sweetened beverages, but also to unsweetened beverages in a large- scale randomized controlled trial.
描述(由申请人提供):食用糖甜味饮料(SSB)与肥胖有关,与体重无关,糖尿病风险和心血管疾病。随着对这些潜在不利影响的公共卫生意识的提高,人工甜味饮料(ASB)的消费量显着增加。这些低热量产品以“饮食”销售,这意味着它们可以促进体重减轻并改善健康状况。但是,没有关于ASB和体重或任何其他健康结果的长期实验研究。最近的一些前瞻性观察研究将ASB的摄入量与增加代谢综合征,2型糖尿病和肥胖的风险增加。在拟议的临床试验中,习惯食用SSB的270名年轻人将被随机分配给三组之一:1)继续消耗习惯水平的SSB; 2)代替ASB代替SSB;或3)用不加糖的饮料代替SSB。每个小组将使用以前成功的工作为基础的方法收到目标饮料1年的送货上门。仔细注意确保治疗保真度,治疗强度的等效性以及避免实验混杂因素。主要的研究终点将是血清甘油三酸酯与HDL-胆固醇浓度的比率。次要终点将包括其他心血管疾病危险因素,体重,饮食质量和口味偏好的变化。 公共卫生相关性:人为甜味的饮料(ASB)出于三个原因提出独特而重要的公共卫生问题:1)在过去的20年中,他们的消费在美国成倍增加; 2)这些产品的习惯饮用者通常比将人造甜味剂摄入固体食物限制在固体食物的人中食用更多的人造甜味剂; 3)ASB由于其液体形式可能具有独特的生物学和行为影响。但是,没有对ASB的长期对照试验和任何健康结果,因此尚未解决至关重要的公共健康问题。本研究旨在通过比较ASB的效果,不仅与糖味饮料,而且在大规模的随机对照试验中不加糖的饮料来填补这一关键的知识差距。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S LUDWIG其他文献

DAVID S LUDWIG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S LUDWIG', 18)}}的其他基金

A Novel Diet-Phenotype Interaction Affecting Body Weight
影响体重的新型饮食-表型相互作用
  • 批准号:
    8528565
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
A Novel Diet-Phenotype Interaction Affecting Body Weight
影响体重的新型饮食-表型相互作用
  • 批准号:
    8101152
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
A Novel Diet-Phenotype Interaction Affecting Body Weight
影响体重的新型饮食-表型相互作用
  • 批准号:
    8307008
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
A Novel Diet-Phenotype Interaction Affecting Body Weight
影响体重的新型饮食-表型相互作用
  • 批准号:
    7986491
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    8508292
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
A Novel Diet-Phenotype Interaction Affecting Body Weight
影响体重的新型饮食-表型相互作用
  • 批准号:
    8685966
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    8311786
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    7947830
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Effects of Diet on Hormones, Metabolism and Body Weight
饮食对激素、新陈代谢和体重的影响
  • 批准号:
    8634981
  • 财政年份:
    2009
  • 资助金额:
    $ 77.5万
  • 项目类别:
Effects of Diet on Hormones, Metabolism and Body Weight
饮食对激素、新陈代谢和体重的影响
  • 批准号:
    7574700
  • 财政年份:
    2009
  • 资助金额:
    $ 77.5万
  • 项目类别:

相似海外基金

OPTIMIZATION OF DOSING REGIMENS OF SULINDAC IN COMBINATION WITH ERLOTINIB FOR SMALL INTESTINAL AND COLON CANCER PREVENTION
优化舒林酸联合埃洛替尼预防小肠癌和结肠癌的给药方案
  • 批准号:
    10020546
  • 财政年份:
    2019
  • 资助金额:
    $ 77.5万
  • 项目类别:
Biochemical and Genetic Markers of Type 2 Diabetes Risk
2 型糖尿病风险的生化和遗传标记
  • 批准号:
    8068430
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    8508292
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    8311786
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
Sugar-sweetened beverages and cardiovascular disease risk: an RCT
含糖饮料和心血管疾病风险:随机对照试验
  • 批准号:
    7947830
  • 财政年份:
    2010
  • 资助金额:
    $ 77.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了